We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Exec Touts 'Lock-Box' Publishing Model for Trial Data
GSK Exec Touts 'Lock-Box' Publishing Model for Trial Data
March 7, 2005
The proliferation of clinical trial registries has started raising red flags among drug companies, some of which are starting to express concerns that making all clinical data publicly available will leave valuable trade secrets exposed.